ArticleGlobal epidemiology2026
Why decision curves cross treat-all and treat-none: A PPV and calibration perspective.
Article in Global epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Net benefit is widely used to assess whether clinical prediction models can improve decision-making, but its interpretation is often difficult in practice. In this note, we show how decision curves can be understood through two familiar quantities: positive predictive value and observed event rates in threshold-defined patient groups. We show that a model has positive net benefit compared with treating no one when, among patients classified as positive, the observed event rate exceeds the decision threshold. Similarly, a model outperforms treating everyone when, among patients classified as negative, the observed event rate is below the decision threshold. These results connect decision-curve performance directly to interpretable forms of threshold-specific calibration. We also describe how positive predictive value curves can complement decision curves by showing, at each threshold, the observed event rate among patients selected for action. Together, these perspectives help explain why a prediction model performs better or worse than default strategies and clarify how decision curve comparisons relate to familiar epidemiological quantities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.